ElRawi Hoda A, Ghanem Nashwa S, ElSayed Naglaa M, Ali Hala M, Rashed Laila A, Mansour Mai M
Int Med Dep Faculty of Medicine, Cairo University, Cairo, Egypt.
Med Biochemestry Dep Faculty of Medicine, Cairo University, Cairo, Egypt.
J Thyroid Res. 2019 Aug 26;2019:3583250. doi: 10.1155/2019/3583250. eCollection 2019.
The current study aimed at assessing vitamin D level and vitamin D receptor polymorphism in hypothyroid Egyptian patients and its effect on hypothyroidism and thyroid morphology, also to find a causal relation between vitamin D and hypothyroidism.
This case-control study was conducted on 35 hypothyroid patients and 35 matched unrelated healthy controls. Total serum 25-hydroxyvitamin D3 and thyroid antibodies were measured using a human ELISA kit. Genotyping was performed by using real-time PCR. HOMA-IR was also calculated (fasting insulin in mIU/L × fasting glucose in mg/dL/405). All subjects were assessed for thyroid morphology by thyroid ultrasonography.
Vitamin D level was lower in hypothyroid patients than in control subjects. Vitamin D was also inversely related to TSH, HOMA-IR, and levels of anti-TG and anti-TPO. VDR polymorphism (Fok1 and Apa1) had no relation to TSH or vitamin D levels in both patients and control groups. Low vitamin D levels were associated with increased thyroid vascularity and nodularity; furthermore, vitamin D was inversely proportional to thyroid gland volume. Correlation of HOMA-IR with the levels of both anti-TG and anti-TPO in the 70 subjects proved that HOMA-IR was positively correlated to both antibodies.
This study confirmed the association of vitamin D deficiency with hypothyroidism, thyroid autoimmunity, increased volume, nodularity, and vascularity of thyroid gland in hypothyroid patients as well as increased HOMA-IR. It proved the association between HOMA-IR and thyroid autoimmunity. The study proved no association between VDR polymorphisms (Fok1 and Apa1) with either vitamin D levels or TSH levels.
本研究旨在评估埃及甲状腺功能减退患者的维生素D水平和维生素D受体多态性及其对甲状腺功能减退和甲状腺形态的影响,并找出维生素D与甲状腺功能减退之间的因果关系。
本病例对照研究对35例甲状腺功能减退患者和35例匹配的无关健康对照进行。使用人ELISA试剂盒测定血清总25-羟维生素D3和甲状腺抗体。通过实时PCR进行基因分型。还计算了HOMA-IR(空腹胰岛素水平(mIU/L)×空腹血糖水平(mg/dL)/405)。通过甲状腺超声对所有受试者的甲状腺形态进行评估。
甲状腺功能减退患者的维生素D水平低于对照组。维生素D还与促甲状腺激素(TSH)、HOMA-IR以及抗甲状腺球蛋白(anti-TG)和抗甲状腺过氧化物酶(anti-TPO)水平呈负相关。维生素D受体多态性(Fok1和Apa1)在患者组和对照组中与TSH或维生素D水平均无关联。低维生素D水平与甲状腺血管增多和结节形成有关;此外,维生素D与甲状腺体积成反比。在70名受试者中,HOMA-IR与anti-TG和anti-TPO水平的相关性证明HOMA-IR与这两种抗体均呈正相关。
本研究证实维生素D缺乏与甲状腺功能减退、甲状腺自身免疫、甲状腺功能减退患者甲状腺体积增大、结节形成和血管增多以及HOMA-IR升高有关。证实了HOMA-IR与甲状腺自身免疫之间的关联。本研究证明维生素D受体多态性(Fok1和Apa1)与维生素D水平或TSH水平均无关联。